Effect of tezepelumab on a composite of severe asthma exacerbations and acute worsening events, CompEx, in the phase 3 NAVIGATOR study
G. Brusselle (Ghent, Belgium), N. Martin (Leicester, United Kingdom), S. Ponnarambil (Cambridge, United Kingdom), G. Hunter (Cambridge, United Kingdom), Å. Hellqvist (Gothenburg, Sweden), M. Fagerås (Gothenburg, Sweden), C. Da Silva (Gothenburg, Sweden)
Source: International Congress 2022 – Recent advances in biological treatments for asthma
Session: Recent advances in biological treatments for asthma
Session type: Oral Presentation
Number: 3678
   
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Brusselle (Ghent, Belgium), N. Martin (Leicester, United Kingdom), S. Ponnarambil (Cambridge, United Kingdom), G. Hunter (Cambridge, United Kingdom), Å. Hellqvist (Gothenburg, Sweden), M. Fagerås (Gothenburg, Sweden), C. Da Silva (Gothenburg, Sweden). Effect of tezepelumab on a composite of severe asthma exacerbations and acute worsening events, CompEx, in the phase 3 NAVIGATOR study. 3678
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|